Umesh A. Badrising

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Efficacy and Safety of Amifampridine in Myasthenia Gravis: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial.

Efficacy and Safety of Amifampridine in Myasthenia Gravis: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial.

Journal: Neurology

Published: April 07, 2026

Efficacy of Pyridostigmine in Myasthenia Gravis: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial.

Efficacy of Pyridostigmine in Myasthenia Gravis: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial.

Journal: Neurology

Published: April 07, 2026

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

Journal: Journal of neuromuscular diseases

Published: February 06, 2026

Correlation of C-Reactive Protein With Severe Fatigue in Patients With Myasthenia Gravis.

Correlation of C-Reactive Protein With Severe Fatigue in Patients With Myasthenia Gravis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: September 18, 2025

Postexercise Facilitation of Reflexes in the Lambert-Eaton Myasthenic Syndrome.

Postexercise Facilitation of Reflexes in the Lambert-Eaton Myasthenic Syndrome.

Journal: The New England journal of medicine

Published: April 07, 2025

Neurological side-effects associated with immune checkpoint inhibitors

Neurological side-effects associated with immune checkpoint inhibitors

Journal: Nederlands tijdschrift voor geneeskunde

Published: January 22, 2025

Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy.

Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy.

Journal: Neurology. Genetics

Published: November 26, 2024

Challenges in international investigator-led rare disease clinical trials and the case for optimism in inclusion body myositis.

Challenges in international investigator-led rare disease clinical trials and the case for optimism in inclusion body myositis.

Journal: Clinical and experimental rheumatology

Published: November 08, 2024

Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale.

Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale.

Journal: Clinical and experimental rheumatology

Published: November 08, 2024

Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.

Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.

Journal: Journal of autoimmunity

Published: July 21, 2024

Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosis.

Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosis.

Journal: Journal of neurology

Published: February 13, 2024

Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis.

Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis.

Journal: Journal of neurology

Published: May 06, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026